Experimental tablet for severe hair loss in teens
Treatments studied
Part of Skin clinical trials.
This trial tests an experimental oral tablet (VC005) in teenagers with severe alopecia areata, a condition that causes patchy hair loss. The goal is to see if the drug is safe and may help regrow hair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 12 and 17 years old (turning 18 during the study is not allowed)
- Weigh at least 40 kg (about 88 pounds)
- Have a confirmed diagnosis of alopecia areata (a type of hair loss where the immune system attacks hair follicles)
- Must not be pregnant, breastfeeding, or planning to become pregnant during the study
- Must not have other types of hair loss or scalp conditions that could affect the study results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
This study tests an oral tablet called upadacitinib for people with severe alopecia areata who have lost at least half of their scalp hair. It aims to see if the drug can safely help hair regrow.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This study tracks the safety and effectiveness of alopecia areata treatments in teenagers aged 12-17. It helps doctors understand which treatments work best and are safest for young people with severe hair loss.
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.